SEC Form 4 · accession 0001683168-19-000079
MEDICINOVA INC · MNOV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Masatsune Okajima
Officer — VP and Head of Japanese Office
Period of report
Jan 9, 2019
Accepted (ET)
Jan 11, 2019 · 4:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001226616
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 9, 2019 | M | 41,250 | $2.20 | A | 153,580 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F2 | $2.20 | Jan 9, 2019 | M | 41,250 | D | — | Jan 29, 2019 | Common Stock | 41,250 | 0 | D |
Explanation of responses
- F1Includes 930 shares acquired under MediciNova's employee stock purchase plan, which are exempt under Rule 16b-3(c).
- F2The option vested over a period of 4 years in equal monthly installments from the 1/30/2009 date of grant and is now fully vested.